Data / Form D filings / CyVek, Inc.
CyVek, Inc.: Form D filings
CyVek, Inc., a biotechnology company in Wallingford, CT, filed 5 Form D notices with the SEC between 2010 and 2014. The latest, on April 7, 2014, reports $10 million sold of a $10 million offering to 1 investor.
Find out what CyVek, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2 BARNES INDUSTRIAL ROAD SOUTH, Wallingford, CT, 06492
- Phone
- (203) 679-0395
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1483965
The full lists. Form D filings in Connecticut: 428 rows, $21.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 7, 2014 | New notice | $10,000,000 | $10,000,000 | $0 | 1 | Apr 2, 2014 | sec.gov |
| Jan 13, 2014 | New notice | $3,000,000 | $1,854,410 | $1,145,590 | 16 | Dec 30, 2013 | sec.gov |
| Feb 7, 2013 | New notice | $5,499,999 | $5,499,999 | $0 | 19 | Jan 30, 2013 | sec.gov |
| Apr 12, 2012 | New notice | $2,999,999 | $2,999,999 | $0 | 22 | Mar 30, 2012 | sec.gov |
| Feb 16, 2010 | New notice | $1,950,000 | $1,950,000 | $0 | 5 | Jan 28, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Kevin Wurzer | Director | |
| Per Hellsund | Executive Officer, Director | |
| Kevin Kevin Rakin | Director | |
| F. Kevin Didden | Executive Officer, Director | |
| Enrique Kevin Posner | Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
- Cloverleaf Bio, Inc. $14.8 million · Sep 9, 2026
Every Form D from the week of Apr 7, 2014 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CyVek, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.